Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel Targets, Novel Treatments: The Changing Landscape of Non-Small Cell Lung Cancer
Dorine de Jong, Jeeban P. Das, Hong Ma, et al.
Cancers (2023) Vol. 15, Iss. 10, pp. 2855-2855
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Advances in Non-Small Cell Lung Cancer: Current Insights and Future Directions
Pankaj Garg, Sulabh Singhal, Prakash Kulkarni, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 14, pp. 4189-4189
Open Access | Times Cited: 10
Fertility and reproductive concerns related to the new generation of cancer drugs and the clinical implication for young individuals undergoing treatments for solid tumors
Hildur Helgadóttir, Alexios Matikas, Josefin Fernebro, et al.
European Journal of Cancer (2024) Vol. 202, pp. 114010-114010
Open Access | Times Cited: 9
Evolving Paradigms in Lung Cancer: Latest Trends in Diagnosis, Management, and Radiopharmaceuticals
Busra Cangut, Rahman Akinlusi, Ava Mohseny, et al.
Seminars in Nuclear Medicine (2025)
Closed Access | Times Cited: 1
Effects of mechanical ventilation on the interstitial extracellular matrix in healthy lungs and lungs affected by acute respiratory distress syndrome: a narrative review
Lou’i Al-Husinat, Saif Azzam, Sarah Al Sharie, et al.
Critical Care (2024) Vol. 28, Iss. 1
Open Access | Times Cited: 7
Repurposing of sericin combined with dactolisib or vitamin D to combat non-small lung cancer cells through computational and biological investigations
Maged W. Helmy, Mohamed Youssef, Imane Yamari, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Exploring Prognostic Factors and Survival Outcomes in Advanced Non-Small Cell Lung Cancer Patients Undergoing First-Line Chemotherapy in Limited-Resource Settings
Chawalit Chayangsu, Jiraporn Khorana, Chaiyut Charoentum, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 335-335
Open Access
Adoptive cell therapies in thoracic malignancies: a comprehensive review
Yago Garitaonaindía, M. Martínez‐Cutillas, Maria Uribarren, et al.
Clinical & Translational Oncology (2025)
Closed Access
Personalized Cancer Therapy: Advancement in Biomarker-Based Treatment Strategies for Non-Small Cell Lung Cancer
Ubaid ur Rehman, Quratulain Badar, Yasser Hijazi Abdoon, et al.
Indus journal of bioscience research. (2025) Vol. 3, Iss. 1, pp. 675-689
Closed Access
Repression of ZNFX1 by LncRNA ZFAS1 mediates tobacco-induced pulmonary carcinogenesis
Sichuan Xi, Jigui Shan, Xinwei Wu, et al.
Cellular & Molecular Biology Letters (2025) Vol. 30, Iss. 1
Open Access
Nanoformulations: Reforming treatment for non-small cell lung cancer metastasis
Shristy Jha, Mangala Hegde, Ruchira Banerjee, et al.
Biochemical Pharmacology (2025), pp. 116928-116928
Closed Access
Genome-wide Analysis Identifies Nuclear Factor 1C as a Novel Transcription Factor and Potential Therapeutic Target in Small Cell Lung Cancer
Vivek Shukla, Haitao Wang, Lyuba Varticovski, et al.
Journal of Thoracic Oncology (2024)
Closed Access | Times Cited: 3
Real-World Treatment Patterns and Survival Outcomes for Patients with Non-Metastatic Non-Small-Cell Lung Cancer in Sweden: A Nationwide Registry Analysis from the I-O Optimise Initiative
Guðrún Óskarsdóttir, Erik Lampa, Anders Berglund, et al.
Cancers (2024) Vol. 16, Iss. 9, pp. 1655-1655
Open Access | Times Cited: 2
Liquid biopsy for the management of NSCLC patients under osimertinib treatment
Aliki Ntzifa, Theodoros Marras, Vassilis Georgoulias, et al.
Critical Reviews in Clinical Laboratory Sciences (2024) Vol. 61, Iss. 5, pp. 347-369
Closed Access | Times Cited: 1
Healthcare Resource Utilization and Associated Costs among Patients with Advanced Non-Small-Cell Lung Cancer Receiving Chemotherapy or Immunotherapy in Spain: A Single-Center, Real-World, Exploratory Study
Jorge Ginés Rubió, Olga Delgado Sánchez, Angel Callejo, et al.
Cancers (2024) Vol. 16, Iss. 11, pp. 2068-2068
Open Access | Times Cited: 1
Imaging at the nexus: how state of the art imaging techniques can enhance our understanding of cancer and fibrosis
Alireza Baniasadi Dahooiyeh, Jeeban P. Das, Conor M. Prendergast, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Immune checkpoint inhibitors with or without radiotherapy in metastatic non‑small cell lung cancer: A meta‑analysis and literature review
Isah Adamu Danbala, Shengqiao Fu, Wanying Sheng, et al.
Oncology Letters (2024) Vol. 28, Iss. 4
Open Access | Times Cited: 1
IGF2BP2 promotes lung adenocarcinoma progression by regulating LOX1 and tumor-associated neutrophils
Long Qian, Zhuqing Ji, Lingyun Mei, et al.
Immunologic Research (2024) Vol. 73, Iss. 1
Closed Access | Times Cited: 1
Transcriptome Analysis of the Inhibitory Effects of 20(S)-Protopanaxadiol on NCI-H1299 Non-Small Cell Lung Cancer Cells
Zhongyi Cong, Xinmin Zhang, Zeqi Lv, et al.
Molecules (2023) Vol. 28, Iss. 15, pp. 5746-5746
Open Access | Times Cited: 3
Microsatellite Instability, Mismatch Repair, and Tumor Mutation Burden in Lung Cancer
Oana Rosca, Oana Vele
Surgical pathology clinics (2023) Vol. 17, Iss. 2, pp. 295-305
Closed Access | Times Cited: 3
Integrated whole‐exome and bulk transcriptome sequencing delineates the dynamic evolution from preneoplasia to invasive lung adenocarcinoma featured with ground‐glass nodules
Dong Zhou, Yan‐qi Li, Quan‐Xing Liu, et al.
Cancer Medicine (2024) Vol. 13, Iss. 11
Open Access
Circulating Hsp70 - a tumor biomarker for lymph node metastases and early relapse in thoracic cancer
Dominik Lobinger, Nicholas Taylor, Verena Messner, et al.
Research Square (Research Square) (2024)
Open Access
Comparative efficacy of targeted therapies and immunotherapy in advanced non-small cell lung cancer: a systematic review
Byron Cristobal Llongo Cali, Jorge Eduardo Paredes Jaramillo, Jennifer Alicia Álvarez Navas, et al.
International Journal of Research in Medical Sciences (2024) Vol. 12, Iss. 9, pp. 3384-3393
Open Access
Identification and treatment of lung cancer oncogenic drivers in a diverse safety net setting
Kalyani Narra, Bassam Ghabach, Vivek Athipatla, et al.
Clinical Lung Cancer (2024)
Closed Access
Cost-effectiveness analysis of a lung cancer screening program in the netherlands: a simulation based on NELSON and NLST study outcomes
Hilde ten Berge, B.A. Willems, Xuanqi Pan, et al.
Journal of Medical Economics (2024), pp. 1-47
Open Access
Treatment Patterns and Health Care Resource Utilization of Patients With Non–Small Cell Lung Cancer in Puerto Rico: The TREATLINES-ONCOLUNG Study
Edgar I. Miranda, Axel Gierbolini-Bermúdez, Rafael Quintana, et al.
JCO Global Oncology (2024), Iss. 10
Open Access
Page 1 - Next Page

Scroll to top